摘要
目的:观察异长春花碱(NVB)加丝裂霉素(MMC)、顺铂(DDP)联合化疗治疗晚期非小细胞肺癌的疗效和毒副作用。方法:52例肺癌中,男性37例,女性15例;初治38例,复治14例;病理为鳞癌29例,腺癌16例,腺鳞癌4例,未分类3例;Ⅲb期33例,Ⅳ期19例。化疗方案为MNP,即MMC6mg/m2D1天静注,NVB25mg/m2D1、8天静注,DDP30mg/m2D1-3天静注。每周期间隔28天,均采用二周期以上评价疗效。结果:完全缓解1例,部分缓解28例,总有效率55.8%;中位缓解期5.2个月,中位生存期11.7个月;主要毒副反应为骨髓抑制。结论:以NVB为主的联合化疗对晚期非小细胞肺癌有较好的疗效和可耐受的毒副作用。
ve: To observe the therapeutic effect and toxic side - effects of the combination chemotherapy with navelbine plus mitomycin c and cisplatin in the treatment of non - small cell lung cancer(NSCLC). Methods: There were totally 52 NSCLC patients, in which male for 37 cases, female for 15 cases. Primary treatment for 38 cases, return treatment for 14 cases. The pathology revealed 29 cases of squamous cell carcinoma, 16 cases of adenocarcinoma, 4 cases of adenosquamous carcinoma, and 3 cases of Unclassified carcinoma. 33 cases had stage Ⅲb disease and 19 had stage Ⅳ . MNP chemotherapeutic regimen: MMC 6mg/m D1, intravenous injection for 1 day, NVB25mg/m2, D1,8, intravenous injection for 2 days, DDP30mg/m2, D1-3, intravenous injection, con-tinuously for 3 days, repeated every 28 days. The evaluation of therapeutic effect was more than 2 cycles. Results:Complete response was observed in 1 patient and partial response was observed in 28 patients with an overall response rate of 55. 8% . The median response duration was 5.2 months and the median survival period was 11.7 months. The principal toxic side- effect was inhibition of bone marrow. Conclusions: Advanced non - small cell lung cancer treated mainly by MNP regimen shows a better therapeutic effect, and toxic side- effects are tolerant.
出处
《临床肿瘤学杂志》
CAS
2001年第4期334-336,共3页
Chinese Clinical Oncology
关键词
非小细胞肺癌
药物疗法
异长春花碱
联合化疗
Non - small cell lung carcinoma ,Drug therapy Navelbine Combined chemotherapy